Insmed Incorporated (INSM)
USD 68.4
(-6.72%)
USD 68.4
(-6.72%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 721.62 Million USD | 595.01% |
| 2022 | 103.82 Million USD | 199.34% |
| 2021 | -104.51 Million USD | 18.29% |
| 2020 | -127.91 Million USD | -41.51% |
| 2019 | -90.39 Million USD | 49.36% |
| 2018 | -178.51 Million USD | 45.17% |
| 2017 | -325.59 Million USD | -202.04% |
| 2016 | -107.8 Million USD | 58.17% |
| 2015 | -257.73 Million USD | -91.81% |
| 2014 | -134.37 Million USD | -42.63% |
| 2013 | -94.2 Million USD | -31.96% |
| 2012 | -71.39 Million USD | -423.22% |
| 2011 | -13.64 Million USD | -28.98% |
| 2010 | -10.57 Million USD | 15.58% |
| 2009 | -12.53 Million USD | -29044.19% |
| 2008 | -43 Thousand USD | 99.67% |
| 2007 | -13.1 Million USD | 37.45% |
| 2006 | -20.95 Million USD | -68.99% |
| 2005 | -12.39 Million USD | -34.44% |
| 2004 | -9.22 Million USD | 68.77% |
| 2003 | -29.52 Million USD | -8.01% |
| 2002 | -27.33 Million USD | 46.66% |
| 2001 | -51.25 Million USD | 28.45% |
| 2000 | -71.62 Million USD | -22502.64% |
| 1999 | -316.9 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 538.41 Million USD | 306.12% |
| 2024 Q2 | 132.57 Million USD | -82.89% |
| 2024 Q1 | 774.96 Million USD | 7.39% |
| 2023 Q1 | 215.8 Million USD | 107.85% |
| 2023 FY | 721.62 Million USD | 595.01% |
| 2023 Q3 | 710.08 Million USD | 23.54% |
| 2023 Q4 | 721.62 Million USD | 1.62% |
| 2023 Q2 | 574.76 Million USD | 166.33% |
| 2022 Q4 | 103.82 Million USD | -74.99% |
| 2022 Q2 | 414.48 Million USD | 29.29% |
| 2022 Q1 | 320.58 Million USD | 406.74% |
| 2022 FY | 103.82 Million USD | 199.34% |
| 2022 Q3 | 415.14 Million USD | 0.16% |
| 2021 Q3 | -245.35 Million USD | 26.76% |
| 2021 FY | -104.51 Million USD | 18.29% |
| 2021 Q1 | -2.15 Million USD | 98.32% |
| 2021 Q2 | -334.97 Million USD | -15451.35% |
| 2021 Q4 | -104.51 Million USD | 57.4% |
| 2020 FY | -127.91 Million USD | -41.51% |
| 2020 Q1 | -29.98 Million USD | 66.83% |
| 2020 Q2 | -243.15 Million USD | -711.05% |
| 2020 Q3 | -189.1 Million USD | 22.23% |
| 2020 Q4 | -127.91 Million USD | 32.36% |
| 2019 Q2 | -232.41 Million USD | -331.6% |
| 2019 Q3 | -161.22 Million USD | 30.63% |
| 2019 Q4 | -90.39 Million USD | 43.94% |
| 2019 Q1 | -53.85 Million USD | 69.83% |
| 2019 FY | -90.39 Million USD | 49.36% |
| 2018 FY | -178.51 Million USD | 45.17% |
| 2018 Q4 | -178.51 Million USD | 30.19% |
| 2018 Q3 | -255.71 Million USD | 21.84% |
| 2018 Q2 | -327.17 Million USD | 14.77% |
| 2018 Q1 | -383.87 Million USD | -17.9% |
| 2017 Q4 | -325.59 Million USD | 13.24% |
| 2017 Q3 | -375.29 Million USD | -946.25% |
| 2017 Q2 | -35.87 Million USD | 49.37% |
| 2017 Q1 | -70.84 Million USD | 34.28% |
| 2017 FY | -325.59 Million USD | -202.04% |
| 2016 Q3 | -165.83 Million USD | 16.36% |
| 2016 FY | -107.8 Million USD | 58.17% |
| 2016 Q4 | -107.8 Million USD | 35.0% |
| 2016 Q2 | -198.28 Million USD | 13.07% |
| 2016 Q1 | -228.08 Million USD | 11.5% |
| 2015 Q3 | -285.71 Million USD | 7.81% |
| 2015 Q1 | -109.56 Million USD | 18.46% |
| 2015 FY | -257.73 Million USD | -91.81% |
| 2015 Q2 | -309.9 Million USD | -182.85% |
| 2015 Q4 | -257.73 Million USD | 9.79% |
| 2014 Q2 | -62.89 Million USD | 22.78% |
| 2014 Q3 | -147.4 Million USD | -134.38% |
| 2014 Q4 | -134.37 Million USD | 8.84% |
| 2014 FY | -134.37 Million USD | -42.63% |
| 2014 Q1 | -81.44 Million USD | 13.55% |
| 2013 Q1 | -59.91 Million USD | 16.08% |
| 2013 Q4 | -94.2 Million USD | 13.05% |
| 2013 FY | -94.2 Million USD | -31.96% |
| 2013 Q3 | -108.35 Million USD | -97.21% |
| 2013 Q2 | -54.94 Million USD | 8.3% |
| 2012 Q4 | -71.39 Million USD | -99.96% |
| 2012 Q2 | -18.6 Million USD | 11.16% |
| 2012 Q1 | -20.94 Million USD | -53.5% |
| 2012 FY | -71.39 Million USD | -423.22% |
| 2012 Q3 | -35.7 Million USD | -91.88% |
| 2011 Q1 | -21.95 Million USD | -107.55% |
| 2011 FY | -13.64 Million USD | -28.98% |
| 2011 Q4 | -13.64 Million USD | -31.85% |
| 2011 Q3 | -10.34 Million USD | -6.5% |
| 2011 Q2 | -9.71 Million USD | 55.75% |
| 2010 Q1 | -19.36 Million USD | -54.52% |
| 2010 Q2 | -11.31 Million USD | 41.56% |
| 2010 Q4 | -10.57 Million USD | -9.06% |
| 2010 Q3 | -9.7 Million USD | 14.28% |
| 2010 FY | -10.57 Million USD | 15.58% |
| 2009 Q1 | -125.76 Million USD | -292376.74% |
| 2009 Q2 | -35.82 Million USD | 71.51% |
| 2009 Q3 | -26.44 Million USD | 26.2% |
| 2009 Q4 | -12.53 Million USD | 52.6% |
| 2009 FY | -12.53 Million USD | -29044.19% |
| 2008 FY | -43 Thousand USD | 99.67% |
| 2008 Q2 | -6.67 Million USD | 25.42% |
| 2008 Q3 | -3.32 Million USD | 50.19% |
| 2008 Q4 | -43 Thousand USD | 98.71% |
| 2008 Q1 | -8.94 Million USD | 31.71% |
| 2007 Q1 | -8.8 Million USD | 57.99% |
| 2007 Q2 | -18.94 Million USD | -115.28% |
| 2007 Q4 | -13.1 Million USD | 15.57% |
| 2007 FY | -13.1 Million USD | 37.45% |
| 2007 Q3 | -15.52 Million USD | 18.09% |
| 2006 Q1 | -55.73 Million USD | -349.53% |
| 2006 Q4 | -20.95 Million USD | 33.2% |
| 2006 Q3 | -31.36 Million USD | 30.0% |
| 2006 Q2 | -44.8 Million USD | 19.6% |
| 2006 FY | -20.95 Million USD | -68.99% |
| 2005 Q4 | -12.39 Million USD | -454.23% |
| 2005 FY | -12.39 Million USD | -34.44% |
| 2005 Q3 | 3.5 Million USD | 140.5% |
| 2005 Q1 | -17.14 Million USD | -85.86% |
| 2005 Q2 | -8.64 Million USD | 49.59% |
| 2004 FY | -9.22 Million USD | 68.77% |
| 2004 Q1 | -24.9 Million USD | 15.64% |
| 2004 Q2 | -14.05 Million USD | 43.57% |
| 2004 Q3 | -7.5 Million USD | 46.57% |
| 2004 Q4 | -9.22 Million USD | -22.81% |
| 2003 Q2 | -22 Million USD | 12.37% |
| 2003 Q3 | -32.18 Million USD | -46.26% |
| 2003 Q4 | -29.52 Million USD | 8.27% |
| 2003 FY | -29.52 Million USD | -8.01% |
| 2003 Q1 | -25.11 Million USD | 8.12% |
| 2002 Q2 | -36.26 Million USD | 14.4% |
| 2002 Q3 | -31.17 Million USD | 14.02% |
| 2002 FY | -27.33 Million USD | 46.66% |
| 2002 Q1 | -42.36 Million USD | 17.34% |
| 2002 Q4 | -27.33 Million USD | 12.32% |
| 2001 Q1 | -72.12 Million USD | -0.69% |
| 2001 Q3 | -57.33 Million USD | 14.24% |
| 2001 Q4 | -51.25 Million USD | 10.62% |
| 2001 FY | -51.25 Million USD | 28.45% |
| 2001 Q2 | -66.86 Million USD | 7.29% |
| 2000 Q3 | -29.37 Million USD | 16.41% |
| 2000 Q1 | -2.61 Million USD | 0.0% |
| 2000 FY | -71.62 Million USD | -22502.64% |
| 2000 Q2 | -35.13 Million USD | -1243.75% |
| 2000 Q4 | -71.62 Million USD | -143.85% |
| 1999 FY | -316.9 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 1389.989% |
| Alkermes plc | -166.73 Million USD | 532.784% |
| Agenus Inc. | 274.13 Million USD | -163.234% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 61.409% |
| Aptorum Group Limited | 1.35 Million USD | -53075.795% |
| Ardelyx, Inc. | 34.51 Million USD | -1990.925% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -16760.28% |
| Bicycle Therapeutics plc | -481.46 Million USD | 249.879% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -1895.465% |
| ChromaDex Corporation | -24.04 Million USD | 3100.749% |
| Chimerix, Inc. | -25.51 Million USD | 2927.997% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -10256.087% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 3147.768% |
| CRISPR Therapeutics AG | -150.84 Million USD | 578.385% |
| Precision BioSciences, Inc. | -85.41 Million USD | 944.889% |
| Dyadic International, Inc. | -6.37 Million USD | 11414.029% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 4629.091% |
| Fortress Biotech, Inc. | 7.66 Million USD | -9314.481% |
| Lantern Pharma Inc. | -21.7 Million USD | 3424.936% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 752.831% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 8546.742% |
| Incyte Corporation | -3.17 Billion USD | 122.728% |
| IO Biotech, Inc. | -140.69 Million USD | 612.882% |
| Jaguar Health, Inc. | 29.39 Million USD | -2355.241% |
| Novavax, Inc. | -298.29 Million USD | 341.916% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -13421.079% |
| Opthea Limited | 28.15 Million USD | -2462.804% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 4398.171% |
| ContextLogic Inc. | -232 Million USD | 411.043% |
| MiMedx Group, Inc. | -33.9 Million USD | 2228.61% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -6978.176% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 31244.221% |
| NextCure, Inc. | -6.47 Million USD | 11241.269% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 1528.922% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 11412.431% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -5832.781% |
| Vaxcyte, Inc. | -368.22 Million USD | 295.972% |
| PDS Biotechnology Corporation | -32.7 Million USD | 2306.189% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -4076.525% |
| Pharming Group N.V. | 109.8 Million USD | -557.189% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 4248.195% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 511.813% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3996.467% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3996.467% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 10263.662% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 12414.334% |
| Acelyrin, Inc. | -216.9 Million USD | 432.692% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 12962.489% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 41957.309% |
| Summit Therapeutics Inc. | 34.67 Million USD | -1981.156% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 10707.379% |
| Senti Biosciences, Inc. | 1.74 Million USD | -41372.414% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 490.895% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 1031.712% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 12003.992% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -723190.802% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -114807.643% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 716.527% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 528.941% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -550.87% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 9600.0% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 658.901% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -10366.455% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 397.743% |
| Immix Biopharma, Inc. | -17.5 Million USD | 4221.237% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 327.854% |
| MEI Pharma, Inc. | -3.7 Million USD | 19576.923% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -5667.884% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -346.155% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -2496.409% |
| Fortress Biotech, Inc. | 7.66 Million USD | -9314.481% |
| Precigen, Inc. | -481 Thousand USD | 150124.948% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -5024.778% |
| AlloVir, Inc. | -62.69 Million USD | 1251.056% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 1397.551% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -1070.207% |
| ImmuCell Corporation | 10.99 Million USD | -6465.815% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 568.141% |
| Onconetix, Inc. | 5.33 Million USD | -13435.188% |
| PureTech Health plc | -167.19 Million USD | 531.599% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 2469.074% |
| Elevation Oncology, Inc. | -19.11 Million USD | 3874.558% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 14799.939% |
| Seer, Inc. | -4.24 Million USD | 17119.34% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 3102.122% |
| Innoviva, Inc. | 255.56 Million USD | -182.365% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 1391.744% |
| ESSA Pharma Inc. | -33.62 Million USD | 2246.3% |
| GlycoMimetics, Inc. | -40.98 Million USD | 1860.718% |
| GT Biopharma, Inc. | -1.02 Million USD | 70777.767% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 1164.603% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -1078.02% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 638.205% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 5307.997% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 2599.377% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 957994.178% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 2438.215% |
| Aptose Biosciences Inc. | -8.19 Million USD | 8905.767% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 23162.188% |
| Soligenix, Inc. | -4.95 Million USD | 14673.48% |
| Century Therapeutics, Inc. | 847 Thousand USD | -85097.166% |
| Kura Oncology, Inc. | -20.11 Million USD | 3686.937% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 1863.231% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 8692.76% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -39512.559% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 22671.786% |
| Autolus Therapeutics plc | -186.59 Million USD | 486.722% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 1563.613% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 361.652% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -2005.813% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -339.027% |
| GRI Bio, Inc. | -1.79 Million USD | 40324.08% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 8133.133% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 2269.829% |
| IGM Biosciences, Inc. | -72.6 Million USD | 1093.885% |
| INmune Bio, Inc. | -25.41 Million USD | 2939.794% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -378.049% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1524.465% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4540.91% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 25113.467% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -1798.251% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 1852.143% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -2163.196% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -90.93% |
| Verastem, Inc. | -37.27 Million USD | 2035.78% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 8053.488% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 1491.423% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 4867.889% |
| Histogen Inc. | -7.48 Million USD | 9738.306% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 3439.779% |
| Surrozen, Inc. | -32.66 Million USD | 2309.221% |
| Organovo Holdings, Inc. | -1.5 Million USD | 47984.539% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 17267.172% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -3705.971% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -27484.862% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -17263.33% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 8710.036% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 1761.111% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 5050.449% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 327.792% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 100039.063% |
| Apollomics, Inc. | -27.39 Million USD | 2734.13% |
| Amarin Corporation plc | -191.04 Million USD | 477.732% |
| Mesoblast Limited | 55.96 Million USD | -1189.459% |
| Turnstone Biologics Corp. | -14.58 Million USD | 5048.025% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 2953.155% |
| Synaptogenix, Inc. | -28.66 Million USD | 2617.733% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 77196.154% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -1380.793% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 83805.975% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 10031.352% |
| Exelixis, Inc. | -73.05 Million USD | 1087.844% |
| Better Therapeutics, Inc. | -860 Thousand USD | 84009.302% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 3105.122% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 398.967% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -97937.404% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 9801.625% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -57445.455% |
| Gritstone bio, Inc. | 39.49 Million USD | -1727.349% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 958.04% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 27515.715% |
| Avid Bioservices, Inc. | 169.72 Million USD | -325.163% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 7993.88% |
| MediWound Ltd. | -5.32 Million USD | 13659.188% |
| OmniAb, Inc. | 9.2 Million USD | -7741.139% |
| Alector, Inc. | -35.63 Million USD | 2124.918% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -739.376% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 14743.263% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -5350.714% |
| Zai Lab Limited | -775 Million USD | 193.112% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -111.895% |
| Aura Biosciences, Inc. | -21.52 Million USD | 3452.474% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 974.903% |
| Immunic, Inc. | -45.34 Million USD | 1691.575% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 473.48% |
| Veracyte, Inc. | -203.82 Million USD | 454.041% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -13.055% |
| FibroGen, Inc. | 56.76 Million USD | -1171.196% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -8003.537% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 25625.259% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 34955.01% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 84.28% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 21698.922% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 534.805% |
| TG Therapeutics, Inc. | 17.86 Million USD | -3939.973% |
| Galecto, Inc. | -21.21 Million USD | 3501.301% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 3133.929% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 54.019% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 3048.758% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 6371.139% |
| XBiotech Inc. | -200.02 Million USD | 460.769% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 958.04% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -15836.837% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 2146.394% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 1034.523% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -12580.021% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 523.449% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 881.194% |
| Vaxxinity, Inc. | 10.13 Million USD | -7022.187% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 1.989% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 6801.802% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 1194.093% |
| NexImmune, Inc. | -3.13 Million USD | 23128.15% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 21000.329% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 4875.319% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 2762.804% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 8139.391% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 579365.503% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 1878.616% |
| Ainos, Inc. | 4.07 Million USD | -17595.751% |
| Pluri Inc. | 22.82 Million USD | -3060.979% |
| Prothena Corporation plc | -608.34 Million USD | 218.62% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 707.649% |
| Celularity Inc. | 65.19 Million USD | -1006.949% |
| Rallybio Corporation | -24.1 Million USD | 3094.025% |
| Cue Biopharma, Inc. | -33.81 Million USD | 2233.771% |
| MeiraGTx Holdings plc | -40.3 Million USD | 1890.531% |
| Omeros Corporation | 331.17 Million USD | -117.896% |
| Humacyte, Inc. | -22.48 Million USD | 3309.197% |
| Immunocore Holdings plc | -358.59 Million USD | 301.236% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 3036.399% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 2435.264% |
| Blueprint Medicines Corporation | 702.83 Million USD | -2.673% |
| CalciMedica, Inc. | -5.53 Million USD | 13149.186% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 483.392% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 7165.009% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 1902.383% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 2270.09% |
| Pulmatrix, Inc. | -10.41 Million USD | 7027.33% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 12173.281% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1991.93% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 747.762% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 1303.823% |
| Cytokinetics, Incorporated | 642.37 Million USD | -12.337% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 12492.581% |
| Nutriband Inc. | -251.65 Thousand USD | 286847.438% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 2215.009% |
| Vor Biopharma Inc. | 4.3 Million USD | -16681.86% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 111.955% |
| Evogene Ltd. | -19.63 Million USD | 3775.359% |
| ProKidney Corp. | -56.23 Million USD | 1383.199% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 1582.618% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 7912.119% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 47.092% |
| CorMedix Inc. | -43.05 Million USD | 1776.139% |
| BioLineRx Ltd. | 7.33 Million USD | -9736.696% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 2727.417% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -1463.742% |
| Atai Life Sciences N.V. | -28.55 Million USD | 2626.858% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -32251.967% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 3262.781% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -3968.903% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 1061.212% |
| MediciNova, Inc. | -50.78 Million USD | 1520.973% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 1015.703% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 3208012.87% |
| GeoVax Labs, Inc. | -6.45 Million USD | 11283.418% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 461.133% |
| Biomea Fusion, Inc. | -166.57 Million USD | 533.223% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 503.196% |
| Mereo BioPharma Group plc | -51.46 Million USD | 1502.048% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 860.849% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 345.65% |
| Absci Corporation | -72.59 Million USD | 1093.994% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -15704.205% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 407.81% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 865.962% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 854.075% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 1946.851% |
| Allakos Inc. | -24.97 Million USD | 2989.369% |
| Imunon, Inc. | -4.21 Million USD | 17224.949% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 4994.994% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 632.954% |
| BioAtla, Inc. | -109.01 Million USD | 761.97% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -97937.404% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 76949.84% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -5930.587% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 3503.386% |
| XOMA Corporation | -29 Million USD | 2588.345% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 4457.609% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 8103.771% |
| aTyr Pharma, Inc. | -7.44 Million USD | 9787.475% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 678.982% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 446.659% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 982.403% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 877.918% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 84088.994% |
| Akari Therapeutics, Plc | -3.84 Million USD | 18867.75% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -44365.121% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 47.742% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 60835.522% |
| UroGen Pharma Ltd. | 4.39 Million USD | -16334.07% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -535.895% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -1002679.245% |
| Orgenesis Inc. | 21.78 Million USD | -3212.615% |
| Entera Bio Ltd. | -10.62 Million USD | 6889.162% |
| GH Research PLC | -78.07 Million USD | 1024.241% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 3337.706% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 2806.853% |
| Xencor, Inc. | 29.64 Million USD | -2334.287% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 36733.953% |
| Replimune Group, Inc. | 1.41 Million USD | -51006.232% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 294749.419% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 670.825% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 60835.522% |
| Portage Biotech Inc. | -4.98 Million USD | 14587.452% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 3208012.87% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 1191.346% |
| OncoCyte Corporation | -6.56 Million USD | 11095.277% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -80311.137% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 15940.135% |
| Purple Biotech Ltd. | -14.13 Million USD | 5204.117% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 3137.633% |
| scPharmaceuticals Inc. | -6.54 Million USD | 11125.516% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 4423.106% |
| HilleVax, Inc. | -165.48 Million USD | 536.064% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 28532.624% |
| Tharimmune, Inc. | -10.93 Million USD | 6698.965% |
| Genprex, Inc. | -6.73 Million USD | 10810.296% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 295.663% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 915.759% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 51607.495% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 21855.555% |
| OKYO Pharma Limited | -826.84 Thousand USD | 87373.598% |
| Savara Inc. | 153 Thousand USD | -471547.059% |
| Curis, Inc. | -23.88 Million USD | 3120.974% |
| Daré Bioscience, Inc. | -5.15 Million USD | 14090.548% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 93090.83% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 11724.034% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -60796.203% |
| BeiGene, Ltd. | -2.25 Billion USD | 132.028% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -5748.523% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 218.648% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 488.833% |
| Erasca, Inc. | -37.21 Million USD | 2039.005% |
| bluebird bio, Inc. | 108.57 Million USD | -564.653% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 56131.052% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -90.528% |
| DBV Technologies S.A. | -126.98 Million USD | 668.267% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 56131.052% |
| Moderna, Inc. | -2.9 Billion USD | 124.824% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 7070.827% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 6739.86% |
| Molecular Templates, Inc. | 707 Thousand USD | -101967.893% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 2400.277% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -108.195% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 979.36% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 886.678% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 2336.056% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 2199.197% |
| MacroGenics, Inc. | -66.98 Million USD | 1177.286% |
| RenovoRx, Inc. | -1.17 Million USD | 61619.182% |
| Adicet Bio, Inc. | -138.78 Million USD | 619.948% |
| Prime Medicine, Inc. | -27.94 Million USD | 2682.656% |
| Aditxt, Inc. | 18.12 Million USD | -3882.256% |
| Adagene Inc. | -87.62 Million USD | 923.51% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 17424.03% |
| Quantum-Si incorporated | -118.55 Million USD | 708.669% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -1904.222% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 9754.828% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 1587.6% |
| SciSparc Ltd. | -2.06 Million USD | 35045.278% |
| Vericel Corporation | 1.27 Million USD | -56409.005% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 6117.662% |
| Minerva Neurosciences, Inc. | 41 Million USD | -1659.866% |
| Generation Bio Co. | 31.44 Million USD | -2194.645% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 511.498% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 2433.603% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -518.922% |
| Invivyd, Inc. | -198.47 Million USD | 463.58% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 899.402% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 30196.49% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 1119.381% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 10673.187% |
| 2seventy bio, Inc. | 181.71 Million USD | -297.116% |
| ADMA Biologics, Inc. | 90.06 Million USD | -701.212% |
| Clene Inc. | 3.34 Million USD | -21505.389% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 8044.992% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 3454.656% |
| GeoVax Labs, Inc. | -6.45 Million USD | 11283.418% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 309.698% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 2875.495% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -306.167% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 17736.764% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -14326.629% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 13953.331% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 653.797% |
| Evaxion Biotech A/S | 5.28 Million USD | -13549.353% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 741.053% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 649.709% |
| Trevena, Inc. | 2.25 Million USD | -31858.37% |
| Surrozen, Inc. | -32.66 Million USD | 2309.221% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 1500.932% |
| Cingulate Inc. | 3.08 Million USD | -23308.829% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 24669.969% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -9940.629% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 7866.681% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 1009.724% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 648.961% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 783.728% |
| Clearmind Medicine Inc. | -3.94 Million USD | 18402.978% |
| Kronos Bio, Inc. | -36.05 Million USD | 2101.498% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -7569.465% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -49389.516% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 1430.028% |
| Statera Biopharma, Inc. | 14.41 Million USD | -4905.547% |
| ImmunityBio, Inc. | 618.22 Million USD | -16.725% |
| Korro Bio, Inc. | -132.94 Million USD | 642.804% |
| Kineta, Inc. | -4.54 Million USD | 15991.213% |
| BioVie Inc. | -17.73 Million USD | 4169.511% |
| Codexis, Inc. | -43.27 Million USD | 1767.676% |
| Celularity Inc. | 65.19 Million USD | -1006.949% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 22871.221% |
| Celcuity Inc. | 6.78 Million USD | -10537.857% |
| Virax Biolabs Group Limited | -3.36 Million USD | 21545.231% |
| Cibus, Inc. | -8.07 Million USD | 9033.152% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 17163.608% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -15690.372% |
| IN8bio, Inc. | -16.38 Million USD | 4503.075% |
| Kodiak Sciences Inc. | -103.87 Million USD | 794.7% |
| Annexon, Inc. | -193.75 Million USD | 472.439% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -2004400.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 4223.779% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 20641.418% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 31.553% |
| Eyenovia, Inc. | 1.25 Million USD | -57230.488% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -2582.104% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 22351.619% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 2270.482% |
| Arcellx, Inc. | -296.95 Million USD | 343.004% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 3799.477% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 1325.682% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 3581.546% |
| Moolec Science SA | 117.61 Thousand USD | -613438.974% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1979.268% |
| Geron Corporation | 14.76 Million USD | -4788.693% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 2003.107% |
| Royalty Pharma plc | 5.65 Billion USD | 87.247% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 610.264% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 10424.456% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 13555.882% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 612.765% |
| Humacyte, Inc. | -22.48 Million USD | 3309.197% |
| Structure Therapeutics Inc. | -124.33 Million USD | 680.365% |
| 89bio, Inc. | -289.05 Million USD | 349.65% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 2958.807% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 40572.238% |
| Genelux Corporation | -6.89 Million USD | 10559.777% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 2423.385% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -763.192% |
| Notable Labs, Ltd. | -9.77 Million USD | 7481.547% |
| Liquidia Corporation | -80.17 Million USD | 1000.045% |
| Mustang Bio, Inc. | -3.73 Million USD | 19415.31% |
| Immunovant, Inc. | -635.22 Million USD | 213.6% |
| Quantum-Si incorporated | -118.55 Million USD | 708.669% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 4208.517% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 17517.813% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -8889.909% |
| Acasti Pharma Inc. | -23 Million USD | 3236.796% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 21530.678% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4540.91% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 623.9% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 23255.846% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 3345.862% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 3986.154% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 526.293% |
| PepGen Inc. | -60.67 Million USD | 1289.418% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 3240.756% |
| United Therapeutics Corporation | -507.7 Million USD | 242.135% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 3872.979% |
| Solid Biosciences Inc. | -47.75 Million USD | 1611.246% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 83805.975% |
| Immuneering Corporation | -54.94 Million USD | 1413.401% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 17267.172% |
| Silo Pharma, Inc. | -3.52 Million USD | 20575.509% |
| Belite Bio, Inc | -87.27 Million USD | 926.873% |
| XOMA Corporation | -29 Million USD | 2588.345% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 1120.722% |
| Bionomics Limited | 227 Million USD | -217.88% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 720.578% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 28588.749% |
| uniQure N.V. | -102.95 Million USD | 800.935% |
| Cassava Sciences, Inc. | -121.13 Million USD | 695.711% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 17424.03% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -1662.155% |
| Forte Biosciences, Inc. | -11.96 Million USD | 6133.108% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 23421.699% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -680673.585% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 22351.619% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -8003.537% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 9830.583% |
| Altimmune, Inc. | -134.48 Million USD | 636.572% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -264.335% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 28588.749% |
| Compugen Ltd. | -12.9 Million USD | 5692.219% |
| Peak Bio, Inc. | 10.34 Million USD | -6878.81% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 255089.399% |
| Benitec Biopharma Inc. | -50.58 Million USD | 1526.634% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 791.618% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -3573.301% |
| Zura Bio Limited | -99.8 Million USD | 823.023% |
| PolyPid Ltd. | 6.17 Million USD | -11595.624% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -873.583% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -3573.301% |
| Instil Bio, Inc. | 75.35 Million USD | -857.589% |
| argenx SE | -2.02 Billion USD | 135.568% |
| Immunome, Inc. | -97.02 Million USD | 843.716% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 3307.913% |
| Verona Pharma plc | -220.44 Million USD | 427.35% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 1105.84% |
| Shattuck Labs, Inc. | -121.42 Million USD | 694.298% |
| CervoMed Inc. | -7.79 Million USD | 9360.032% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 489.016% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 16601.715% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 647.761% |
| Moolec Science SA | 117.61 Thousand USD | -613438.974% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 31639.653% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -4438.953% |
| AnaptysBio, Inc. | -18.15 Million USD | 4075.649% |
| Design Therapeutics, Inc. | -18.15 Million USD | 4075.868% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 1125.305% |
| NeurAxis, Inc. | 145.7 Thousand USD | -495177.968% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -6324.679% |
| Lumos Pharma, Inc. | -28.49 Million USD | 2632.622% |
| Achilles Therapeutics plc | -126.92 Million USD | 668.545% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 1105.84% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 110148.343% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 3573.698% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -49389.516% |
| Nutriband Inc. | -251.65 Thousand USD | 286847.438% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 5578.855% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 9799.194% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -112.118% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -2940.32% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 261.266% |
| Palisade Bio, Inc. | -12.06 Million USD | 6082.094% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 614.3% |
| Beam Therapeutics Inc. | -262.72 Million USD | 374.671% |
| Neurogene Inc. | -131.95 Million USD | 646.868% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -3207.756% |
| AEON Biopharma, Inc. | -4.88 Million USD | 14887.295% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 291.314% |
| Sesen Bio, Inc. | -112.55 Million USD | 741.138% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 822.632% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 30836.1% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 1949.075% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 966.478% |
| Athira Pharma, Inc. | -88.99 Million USD | 910.818% |
| Vaccinex, Inc. | -1.28 Million USD | 56126.398% |
| HCW Biologics Inc. | 2.85 Million USD | -25160.828% |
| XOMA Corporation | -29 Million USD | 2588.345% |
| Nektar Therapeutics | 210.24 Million USD | -243.236% |
| Arvinas, Inc. | -313.8 Million USD | 329.962% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -44365.121% |
| Merus N.V. | -192.88 Million USD | 474.121% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -1103.001% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 10500.98% |
| Rezolute, Inc. | -68.16 Million USD | 1158.591% |
| Clene Inc. | 3.34 Million USD | -21505.389% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 5572.207% |
| BeyondSpring Inc. | -13.75 Million USD | 5346.238% |
| Synlogic, Inc. | -6.68 Million USD | 10894.615% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -63534.921% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 8634.831% |
| Peak Bio, Inc. | 10.34 Million USD | -6878.81% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 975.54% |
| Krystal Biotech, Inc. | -350.23 Million USD | 306.039% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -481.366% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 527.004% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 22956.734% |
| MannKind Corporation | 143.89 Million USD | -401.477% |
| Ikena Oncology, Inc. | -109.15 Million USD | 761.091% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 9631.37% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 2280.121% |
| Gossamer Bio, Inc. | 180.35 Million USD | -300.111% |
| CohBar, Inc. | -5.93 Million USD | 12267.471% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 2525.777% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -15704.205% |
| Legend Biotech Corporation | -949.39 Million USD | 176.008% |
| Mural Oncology plc | -255.84 Million USD | 382.056% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -2140.012% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 15418.931% |
| Disc Medicine, Inc. | -358.28 Million USD | 301.412% |
| Champions Oncology, Inc. | 4.81 Million USD | -14896.259% |
| REGENXBIO Inc. | 54.76 Million USD | -1217.594% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 268452.999% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 577.818% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 8107.318% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 994.389% |
| Vaxart, Inc. | -8.24 Million USD | 8856.462% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 1538.064% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 667.465% |
| Cellectis S.A. | -43.85 Million USD | 1745.468% |
| Longeveron Inc. | -2.9 Million USD | 24914.993% |
| Repare Therapeutics Inc. | -107.85 Million USD | 769.046% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 25.482% |
| Inozyme Pharma, Inc. | 12 Million USD | -5911.496% |
| Revolution Medicines, Inc. | -608.2 Million USD | 218.648% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 58768.293% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 372.189% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 580.849% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 4711.874% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 97616.216% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 107.545% |
| Denali Therapeutics Inc. | -74.86 Million USD | 1063.895% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 6117.662% |
| Veru Inc. | 4.77 Million USD | -14996.751% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 6516.681% |
| Cingulate Inc. | 3.08 Million USD | -23308.829% |
| Passage Bio, Inc. | 4.58 Million USD | -15638.713% |
| Context Therapeutics Inc. | -14.44 Million USD | 5093.97% |
| Exicure, Inc. | 5.84 Million USD | -12237.494% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 413.236% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 1923.654% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -4498.942% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 1326.807% |
| Nuvalent, Inc. | -335.38 Million USD | 315.16% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -41507.735% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 1068.852% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 8217.21% |
| OmniAb, Inc. | 9.2 Million USD | -7741.139% |
| Anew Medical, Inc. | 1.43 Million USD | -50276.1% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -4305.023% |
| Lipocine Inc. | -4.75 Million USD | 15277.328% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 757.046% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -4637.837% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1524.465% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -2799.004% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 10836.795% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 1196.237% |
| Ocugen, Inc. | -32.52 Million USD | 2318.935% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 943.26% |
| Q32 Bio Inc. | -37.94 Million USD | 2001.602% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 115007.643% |
| Alumis Inc. Common Stock | -13.52 Million USD | 5433.875% |
| Equillium, Inc. | -22.39 Million USD | 3322.669% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 2922.356% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 2311.742% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 291175.57% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -438.354% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -22464.728% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -219610.694% |
| Dominari Holdings Inc. | 195 Thousand USD | -369961.538% |
| Edesa Biotech, Inc. | -5.26 Million USD | 13801.013% |
| vTv Therapeutics Inc. | -8.91 Million USD | 8192.632% |
| Bio-Techne Corporation | 267.74 Million USD | -169.516% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 4551.971% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 711.056% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 8687.647% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 5804.055% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 394.396% |
| Nkarta, Inc. | 57.29 Million USD | -1159.394% |
| BioCardia, Inc. | 212 Thousand USD | -340286.792% |
| Iterum Therapeutics plc | 13.43 Million USD | -5269.996% |